Paul Beninger ’73 P’09 - Saving Magic Johnson: The Long and Complicated Race for Cures

Paul Beninger ’73 P’09 is an associate professor of Public Health & Community Medicine at Tufts University where he also directs the MD/MBA and MBS/MBA programs. He has more than three decades of experience as a regulator and member of the Senior Executive Service in the U.S. Food and Drug Administration (FDA), as a manager and executive in the pharmaceutical industry, including pharmacovigilance, and as a member of the academic community.

Beninger began his career in drug development in 1987 at the FDA, first as a reviewer and manager for drugs to combat HIV/AIDS and opportunistic infection and then as a division director for medical devices. He joined Merck & Company in 1995 and developed experience in regulatory affairs, medical affairs and drug safety in the areas of anti-infective drug and biological products, vaccines, anti-diabetic drug products and oncology drug products, before joining Genzyme as vice-president of pharmacovigilance in 2006 where he worked until 2017.